Artis Ventures
Early-stage companies leveraging frontier technologies (AI, gene editing, synthetic biology, advanced diagnostics) to transform human health, cure disease, and strengthen global resilience. Data-driven, engineering-first approaches combined with cellular biology create transformative healthcare...
Check size: $50K – $25.0M
Stages: Pre-Seed, Seed, Series A
Sectors: Biotech & Life Sciences, Healthcare & Digital Health